Among the litany of modest changes that the Trump administration rolled out in its plan to lower drug prices is one big idea that’s already worrying drug makers: a push to consolidate the two disparate Medicare programs that pay for prescription drugs.

Health and Human Services Secretary Alex Azar has been touting the idea all week as a way to bring the negotiating power of the Part D program, which covers seniors’ prescription drugs, into the Part B program, which covers other treatments. “Let me be really clear about this: We are going to bring negotiation to Part B drugs, and we are going to give Part D plans more bargaining power. It’s going to happen,” he said.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • There is no reason not to and multiple reasons we should IF there are negotiations going on with Big Pharma to reduce drug prices for our Healthcare. The fact that we, Americans, should pay more than others countries is PRICE GAUGING. That should be against the law..if it’s not already.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy